Use of Apamarga Kshar Taila in management of Sharavika Prameha Pidika (Diabetic Ulcers)

AN OPEN RANDOMISED CLINICAL CONTROL TRIAL OF EFFECT OF APAMARGA KSHAR TAILA WITH ADJUVANT DRUG THERAPY IN MANAGEMENT OF SHARAVIKA PRAMEHA PIDIKA WITH SPECIAL REFERENCE TO DIABETIC ULCER - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/08/093163

Enrollment

Registered

2025-08-18

Start date

Unknown

Completion date

Unknown

Last updated

2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E115- Type 2 diabetes mellitus with circulatory complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patient suffering from Non Insulin Dependent Diabetes mellitus and Insulin Dependent Diabetes mellitus

Exclusion criteria

Exclusion criteria: Patient suffering from Malignant ulcer Tubercular ulcer Venous ulcer HIV and HBsAg

Design outcomes

Primary

Measure	Time frame
To Evaluate the efficacy of Apamarga Kshar Taila with adjuvant drug therapy in management of Shravika Prameha PidikaTimepoint: at 1st day, 5thday and 15th day	—

Secondary

Measure	Time frame
To compare the efficacy of EUSOL & Apamarga Kshar taila with Adjuvant Drug Therapy in manangement of Sharavika Prameha PidikaTimepoint: at 1st day , 5th day & 15th day	—

Countries

India

Contacts

Public ContactDr Manoj Patil

Hon Shri Annasaheb Dange Ayurved Medical College Post Graduate and Research Centre Ashta

dr.patilmanoj77@gmail.com9422613195

Outcome results